Journal profile · Pharmacology & Pharmacy
Indian Journal of Pharmacology
ISSN 0253-7613 · eISSN 1998-3751 · Wolters Kluwer Medknow Publications · INDIA · Bimonthly
Indian Journal of Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.13; JCR Q4 (journal website); fully open access; median 164 days to acceptance (94 articles, last 24 months); community-reported acceptance: easy; 72 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Indian Journal of Pharmacology is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural Antidiabetic Agents Studies, Drug-Induced Adverse Reactions and Drug-Induced Hepatotoxicity and Protection, together about 19.7% of its articles. Its main subfields are Pharmacology. (generated from OpenAlex topic counts and CAS ranking data)
Indian Journal of Pharmacology accepts, in English, review articles, articles for educational forum, original research articles (full length and short communications), letter to editor, case reports and interesting fillers. Articles concerning all aspects of pharmacology will be considered. Articles of general interest (e.g. methods, therapeutics, medical education, interesting websites, new drug information and commentary on a recent topic) are also welcome.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural Antidiabetic Agents StudiesMedicine6.7%
- Drug-Induced Adverse ReactionsMedicine6.7%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics6.3%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics6%
- Pharmacological Effects and Toxicity StudiesMedicine5%
- Antibiotics Pharmacokinetics and EfficacyMedicine4.8%
- Phytochemicals and Medicinal PlantsMedicine4.7%
- Neuroscience and Neuropharmacology ResearchNeuroscience4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · PHARMACOLOGY & PHARMACY · rank 307/356
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.13LetPub ·
- Impact factor (publisher)
- 1.2Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.53LetPub ·
- h-index
- 52LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 1,451OpenAlex ·
- 2-year mean citedness
- 1.23OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 89.6%LetPub ·
Volume
- Articles per year
- 54LetPub ·
Articles by year OpenAlex count · 3,617 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 90 | 90 | 28 |
| 2025 | 72 | 72 | 83 |
| 2024 | 82 | 82 | 190 |
| 2023 | 75 | 75 | 296 |
| 2022 | 75 | 75 | 570 |
| 2021 | 96 | 90 | 802 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
164 daysMedian, submission to acceptance · P25–P75 72 days – 315 days
- Acceptance to online
- median 62 days (95 articles)
- Submission to online
- median 281 days
- Sample
- 94 articles with submission and acceptance dates (175 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- INDIA
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 0253-7613
- Electronic ISSN
- 1998-3751
- Latest issue on the website
- Volume 58, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Indian Journal of Pharmacology
What CAS zone is Indian Journal of Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Pharmacology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Indian Journal of Pharmacology?
The latest impact factor listed by LetPub is 1.13; CiteScore 2.1, h-index 89.
How long does peer review take at Indian Journal of Pharmacology?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 164 days (interquartile range 72–315 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Indian Journal of Pharmacology in?
The journal's website gives JCR Q4; by category, PHARMACOLOGY & PHARMACY Q4 (307/356). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Indian Journal of Pharmacology?
According to LetPub and DOAJ records, Indian Journal of Pharmacology is indexed in SCIE and Scopus.
Is Indian Journal of Pharmacology open access, and what is the APC?
Indian Journal of Pharmacology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .